LLM-Enhanced Multimodal Fusion of SPECT Radiomics and Clinical Data for Predicting 131I Therapeutic Response in Differentiated Thyroid Cancer
{{output}}
Background: Patients with differentiated thyroid cancer (DTC) treated with radioactive iodine (RAI) remain at risk of adverse outcomes. Early prediction of RAI efficacy is critical for optimizing clinical management. ... ...
